BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
66.15
+0.14 (0.20%)
Nov 5, 2024, 1:24 PM EST - Market open
BioMarin Pharmaceutical Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$94.45
Upside
+42.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $93 → $81 | Hold | Maintains | $93 → $81 | +22.46% | Oct 30, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $93 → $84 | Hold | Maintains | $93 → $84 | +26.99% | Oct 30, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $110 → $90 | Buy | Maintains | $110 → $90 | +36.06% | Oct 30, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $110 → $109 | Buy | Maintains | $110 → $109 | +64.79% | Oct 30, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $80 | Hold | Reiterates | $80 | +20.95% | Oct 30, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +58.74% | Oct 30, 2024 |
| UBS | UBS | Strong Buy Maintains $104 → $106 | Strong Buy | Maintains | $104 → $106 | +60.25% | Oct 30, 2024 |
| Baird | Baird | Hold Maintains $72 → $65 | Hold | Maintains | $72 → $65 | -1.73% | Oct 30, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 30, 2024 |
| Raymond James | Raymond James | Buy Initiates $79 | Buy | Initiates | $79 | +19.43% | Oct 10, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $85 → $80 | Hold | Maintains | $85 → $80 | +20.95% | Oct 4, 2024 |
| Barclays | Barclays | Buy Maintains $110 → $86 | Buy | Maintains | $110 → $86 | +30.02% | Oct 4, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $95 → $78 | Hold | Maintains | $95 → $78 | +17.92% | Sep 17, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $118 → $90 | Strong Buy | Maintains | $118 → $90 | +36.06% | Sep 17, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $115 → $90 | Buy | Maintains | $115 → $90 | +36.06% | Sep 17, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $100 → $85 | Hold | Maintains | $100 → $85 | +28.51% | Sep 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.